Selective laser trabeculoplasty (SLT)
Sponsors
Ellex Medical Pty. Ltd. (Australia), University of Zurich, University Hospital, Geneva, Sight Sciences, Inc., Western University, Canada
Conditions
GlaucomaGlaucoma and Ocular HypertensionIntraocular PressureOcular HypertensionOpen Angle GlaucomaOpen-Angle GlaucomaOpen-angle GlaucomaPrimary Open Angle Glaucoma of Both Eyes
Phase 4
Unknown Phase
Selective Laser Trabeculoplasty for Primary Angle-Closure Glaucoma: a pilot case study
Active, not recruitingISRCTN42557387
Start: 2005-07-01Target: 150Updated: 2015-01-13
Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients
NCT01467388
Start: 2011-11-30End: 2015-12-31Target: 200Updated: 2015-01-06
Prospective,Randomized,Controlled Study to Assess Efficacy,Safety, and Tolerability of SLT vs. PLT in Patients With POAG
TerminatedNCT02231515
Start: 2014-04-30End: 2016-06-30Updated: 2023-05-18
Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma
TerminatedNCT02928289
Start: 2017-01-23End: 2019-01-17Updated: 2025-11-14
Is the Reduction in IOP After Treatment of 180 Degrees Equivalent to Treatment of 360 Degrees With SLT?
CompletedNCT03529591
Start: 2018-06-29End: 2021-05-03Updated: 2022-05-04
Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT)
CompletedNCT04519814
Start: 2020-06-30End: 2022-09-13Updated: 2024-12-19
The Effects of DSLT and SLT on the Corneal Endothelium: A GLAUrious Trial Sub-Study
CompletedNCT04758598
Start: 2021-03-01End: 2022-05-06Updated: 2023-01-17